BG62000B1 - Нови естери на никотиновата киселина - Google Patents

Нови естери на никотиновата киселина Download PDF

Info

Publication number
BG62000B1
BG62000B1 BG99289A BG9928994A BG62000B1 BG 62000 B1 BG62000 B1 BG 62000B1 BG 99289 A BG99289 A BG 99289A BG 9928994 A BG9928994 A BG 9928994A BG 62000 B1 BG62000 B1 BG 62000B1
Authority
BG
Bulgaria
Prior art keywords
compound
group
compounds
groups
formula
Prior art date
Application number
BG99289A
Other languages
Bulgarian (bg)
English (en)
Other versions
BG99289A (bg
Inventor
Torbjoern Lundstedt
Lisbeth Abramo
Goeran Pettersson
Gunnar Andersson
Curt Nordvi
Jin Chang Wu
Anders Bjoerk
Catarina Ludwig
Elisabeth Seifert
Arne Nilsson
Original Assignee
Pharmacia Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharmacia Ab filed Critical Pharmacia Ab
Publication of BG99289A publication Critical patent/BG99289A/bg
Publication of BG62000B1 publication Critical patent/BG62000B1/bg

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/79—Acids; Esters
    • C07D213/80—Acids; Esters in position 3
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Psychiatry (AREA)
  • Vascular Medicine (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Urology & Nephrology (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
BG99289A 1992-06-25 1994-12-22 Нови естери на никотиновата киселина BG62000B1 (bg)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE9201956A SE9201956D0 (sv) 1992-06-25 1992-06-25 Novel nicotinicacid esters
PCT/SE1993/000565 WO1994000434A1 (en) 1992-06-25 1993-06-23 Novel nicotinic acid esters

Publications (2)

Publication Number Publication Date
BG99289A BG99289A (bg) 1995-09-29
BG62000B1 true BG62000B1 (bg) 1998-12-30

Family

ID=20386602

Family Applications (1)

Application Number Title Priority Date Filing Date
BG99289A BG62000B1 (bg) 1992-06-25 1994-12-22 Нови естери на никотиновата киселина

Country Status (27)

Country Link
US (1) US5658910A (ja)
EP (2) EP0673368B1 (ja)
JP (1) JP3306827B2 (ja)
KR (1) KR100302216B1 (ja)
CN (1) CN1085981C (ja)
AT (2) ATE209634T1 (ja)
AU (1) AU681346B2 (ja)
BG (1) BG62000B1 (ja)
CA (1) CA2139112C (ja)
CZ (1) CZ281975B6 (ja)
DE (2) DE69331234T2 (ja)
DK (1) DK0673368T3 (ja)
EE (1) EE03122B1 (ja)
ES (1) ES2169044T3 (ja)
FI (1) FI107151B (ja)
HU (2) HU220613B1 (ja)
IL (1) IL106135A (ja)
NO (1) NO302945B1 (ja)
NZ (1) NZ253823A (ja)
PH (1) PH31417A (ja)
PT (1) PT673368E (ja)
RO (1) RO115725B1 (ja)
RU (1) RU2127732C1 (ja)
SE (1) SE9201956D0 (ja)
SK (1) SK279393B6 (ja)
WO (1) WO1994000434A1 (ja)
ZA (1) ZA934596B (ja)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6632823B1 (en) * 1997-12-22 2003-10-14 Merck & Co., Inc. Substituted pyridine compounds useful as modulators of acetylcholine receptors
EP1087963B1 (en) 1998-06-19 2004-08-25 Chiron Corporation Inhibitors of glycogen synthase kinase 3
US7045519B2 (en) * 1998-06-19 2006-05-16 Chiron Corporation Inhibitors of glycogen synthase kinase 3
UA126099C2 (uk) * 2018-05-09 2022-08-10 ЕлДжи КЕМ, ЛТД. Сполука, яка виявляє інгібувальну активність відносно ентеропептидази

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE8701375D0 (sv) * 1987-04-02 1987-04-02 Leo Ab Novel pyridyl- and pyrimidyl derivatives
SE9201239D0 (sv) * 1992-04-21 1992-04-21 Kabi Pharmacia Ab Agents for treating substance abuse disorders
SE9202265D0 (sv) * 1992-07-31 1992-07-31 Kabi Pharmacia Ab Novel- pyridyl and pyrimidylpiperazine derivatives

Also Published As

Publication number Publication date
CA2139112C (en) 2006-03-21
ATE209634T1 (de) 2001-12-15
PH31417A (en) 1998-10-29
ES2169044T3 (es) 2002-07-01
DE69331234D1 (de) 2002-01-10
FI946085A (fi) 1994-12-23
PT673368E (pt) 2002-05-31
DK0673368T3 (da) 2002-03-18
CN1085981C (zh) 2002-06-05
FI107151B (fi) 2001-06-15
HU220613B1 (hu) 2002-03-28
SK158594A3 (en) 1995-07-11
JPH07508517A (ja) 1995-09-21
EP1120410B1 (en) 2004-10-06
CN1086811A (zh) 1994-05-18
CZ281975B6 (cs) 1997-04-16
WO1994000434A1 (en) 1994-01-06
AU681346B2 (en) 1997-08-28
KR950702186A (ko) 1995-06-19
IL106135A (en) 1999-01-26
JP3306827B2 (ja) 2002-07-24
HU210875A9 (en) 1995-08-28
SK279393B6 (sk) 1998-11-04
SE9201956D0 (sv) 1992-06-25
CZ327494A3 (en) 1995-09-13
NO945022D0 (no) 1994-12-23
KR100302216B1 (ko) 2001-11-22
AU4519393A (en) 1994-01-24
CA2139112A1 (en) 1994-01-06
RU94046310A (ru) 1996-10-27
BG99289A (bg) 1995-09-29
NO945022L (no) 1995-02-13
EP1120410A1 (en) 2001-08-01
EP0673368B1 (en) 2001-11-28
ZA934596B (en) 1994-02-14
DE69331234T2 (de) 2002-08-08
EP0673368A1 (en) 1995-09-27
HUT71406A (en) 1995-11-28
NO302945B1 (no) 1998-05-11
EE03122B1 (et) 1998-10-15
DE69333655D1 (de) 2004-11-11
ATE278671T1 (de) 2004-10-15
NZ253823A (en) 1996-01-26
RO115725B1 (ro) 2000-05-30
HU9403786D0 (en) 1995-02-28
RU2127732C1 (ru) 1999-03-20
IL106135A0 (en) 1993-10-20
US5658910A (en) 1997-08-19
FI946085A0 (fi) 1994-12-23

Similar Documents

Publication Publication Date Title
US5135931A (en) Pyridinylpiperazine derivatives
RU2021269C1 (ru) Пиридил- или пиримидилсодержащие производные пиперазина или 1,4-диазациклогептана или их фармакологически активные кислотно-аддитивные соли, обладающие психотропным действием
EP0652867B1 (en) Novel pyridyl- and pyrimidylpiperazine derivatives
BG62000B1 (bg) Нови естери на никотиновата киселина
NL8100998A (nl) Piperazinederivaat.
GB2162843A (en) Piperazine derivatives
KR100226328B1 (ko) 4-(4-또는6-(트리플루오로메틸-2-피리디닐))-1-피페라지닐알킬치환된락탐
CZ230893A3 (en) Benzindene derivatives
US20200087264A1 (en) Novel selective ligand for dopamine d3 receptor, preparation method therefor, and pharmaceutical application thereof
NO179409B (no) Psykoaktive 4-[4-eller 6-(trifluormetyl-2-pyridinyl)Å-1-piperazinyl-alkylsubstituerte laktamer og anvendelse derav